Patent · US Active

Crystal form of thieno[2,3-c]pyridazine-4(1H)-one compound, preparation method therefor and use thereof

US11673899B2 · kind B2 · utility

0Cited by

1References

5Claims

0Family size

Assignees

ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD. · CN
Medshine Discovery Inc. · CN

Inventors

Juan Yu · Fujian, CN
Zhiliang Chen · Shanghai, CN
Shicong Wang · Zhangzhou, CN
Tingting Yin · Fujian, CN
Kaili Jian · Zhangzhou, CN
Xiaoping Zheng · Shanghai, CN
Zhigan Jiang · Shanghai, CN
Haiying He · Shanghai, CN

Key dates

Filing date	Dec 4, 2020
Grant date	Jun 13, 2023
Priority date	—
Expiry date	Dec 4, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are a crystal form of a thieno[2,3-c]pyridazine-4(1H)-one compound, a preparation method therefor and the use thereof in the preparation of a drug as an inhibitor of ACC1 and ACC2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.